相关实验视频

Updated: Jun 6, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

在血液癌症中可测量的残留疾病

Krzysztof Jamroziak¹, Bartosz Puła²

¹Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.

|November 27, 2024

概括

最小残留疾病 (MRD) 指治疗后剩余的癌细胞,表明潜在的复发和不良预后. 检测MRD对于有效的癌症管理和改善患者治疗结果至关重要.

科学领域:

在瘤学瘤学.
血液学血液学血液学
癌症生物学癌症生物学

背景情况:

最小残留疾病 (MRD) 表示治疗后癌细胞的存在.
检测MRD与疾病复发和患者预后有关.

研究的目的:

定义和讨论最小残留疾病 (MRD) 在癌症治疗中的重要性.
突出MRD对预后和复发的影响.

主要方法:

关于MRD检测及其临床相关性的现有文献的审查.
分析与最小残留疾病相关的预后因素.

主要成果:

MRD是治疗疗效的关键指标.
MRD 的存在与更高的复发风险和更差的存活率相关.

结论:

准确的MRD评估对于个性化癌症治疗至关重要.
监测MRD可以指导治疗调整并改善患者管理策略.

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

相关概念视频